HomeCARA • NASDAQ
add
Cara Therapeutics Inc
Previous close
$4.75
Day range
$4.44 - $4.83
Year range
$2.71 - $13.80
Market cap
21.71M USD
Avg Volume
230.18K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 2.56M | -47.47% |
Operating expense | 7.84M | -75.67% |
Net income | -12.48M | 55.49% |
Net profit margin | -488.11 | 15.27% |
Earnings per share | -1.42 | 77.30% |
EBITDA | -6.23M | 78.40% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 42.04M | -46.48% |
Total assets | 51.33M | -55.50% |
Total liabilities | 50.62M | 70.47% |
Total equity | 707.00K | — |
Shares outstanding | 4.57M | — |
Price to book | 31.67 | — |
Return on assets | -25.44% | — |
Return on capital | -30.45% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -12.48M | 55.49% |
Cash from operations | -13.98M | 28.82% |
Cash from investing | 2.50M | -89.20% |
Cash from financing | -694.00K | -162.19% |
Net change in cash | -12.18M | -363.25% |
Free cash flow | -9.35M | -2.72% |
About
Founded
2004
Headquarters
Website
Employees
55
